A
process that edits the genetic instructions for manufacturing proteins has been
implicated in cancer for the first time.
A process that edits the genetic
instructions for manufacturing proteins has been implicated in cancer for the
first time.
The discovery, made by scientists
in Hong Kong and Singapore, found that RNA editing of a specific protein may be
responsible for turning normal liver cells into cancer cells.
The body’s genetic code is stored
in DNA molecules that contain all the genes in the human genome. However, it is
the protein product of each gene that is responsible for its carrying out its
function in the cell.
To manufacture proteins, the
genetic blueprint found in DNA molecules must be copied and sent to the cell’s
protein-producing factories in the form of a message stored in RNA molecules.
Proteins are then manufactured based on the genetic instructions found in the
RNA message.
Scientists had previously
identified a process, known as RNA editing, that changes the instructions found
in the RNA message by substituting one alphabet of the code for another. This
RNA editing process may cause the production of a protein that is structurally
and functionally very different from the one that the genetic blueprint had
intended.
Although other studies have
suggested a link between RNA editing and cancer, it was not known if higher
levels of RNA editing can promote cancer development.
In this study, published in Nature
Medicine, the scientists used high-throughput sequencing technology to
analyze the RNA messages found within liver tumors and compared them to those
found in normal liver tissues.
Through their genomic analysis,
the researchers identified a gene known as AZIN1 that showed
high levels of RNA editing in the liver tumors compared to the normal tissues.
Increased levels of edited AZIN1 RNA may be a cause of liver
cancer as the RNA editing process changed the AZIN1 protein
product into a form which promoted the development of cancer.
To verify their findings, the
team analyzed samples from some 180 liver cancer patients in China and
confirmed that around half of the tumors showed signs of increased AZIN1 RNA
editing. They also found that RNA editing of the AZIN1 gene in tumours is
significantly associated with the presence of liver cirrhosis, tumor
recurrence, and poorer survival rate.
The discovery also raises the
possibility of targeting abnormalities in the RNA message for cancer therapy.
“Up to now, scientists have
focused on studying DNA, not RNA. Because RNA can be more easily modified than
DNA, it suggests that therapeutic approaches are potentially available,” said
Professor Daniel Tenen, a senior author of the study.
The article can be found
at: Chen et al. (2013) Recoding RNA Editing Of AZIN1 Predisposes To
Hepatocellular Carcinoma.
Source: NUS.
No comments:
Post a Comment